H. Khoury et al., ESSENTIAL THROMBOCYTHEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, Bone marrow transplantation, 22(1), 1998, pp. 107-109
Allogeneic transplant recipients are at high risk of developing second
ary malignancies as a late complication of therapy. We report a case o
f essential thrombocythemia occurring 8 years following bone marrow tr
ansplantation (BMT) for chronic myelogenous leukemia.